Julius J. Michel

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Clinical decision support in hematological malignancies using a case-grounded AI agent.

Clinical decision support in hematological malignancies using a case-grounded AI agent.

Journal: Nature medicine
Published: January 27, 2026

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Journal: Cancer cell
Published: July 23, 2025

Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial.

Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial.

Journal: Cell
Published: May 13, 2025

Type I interferon drives T cell responses to amyloid beta in the central nervous system.

Type I interferon drives T cell responses to amyloid beta in the central nervous system.

Journal: Nature communications
Published: October 23, 2024

Molecular recording of cellular protein kinase activity with chemical labeling.

Molecular recording of cellular protein kinase activity with chemical labeling.

Journal: Nature chemical biology
Published: September 25, 2024

The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.

The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.

Journal: Science immunology
Published: May 03, 2024

T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells.

T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells.

Journal: Neuro-oncology advances
Published: October 05, 2022

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

Journal: Journal for immunotherapy of cancer
Published: September 26, 2022

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.

Journal: Neuro-oncology
Published: May 24, 2022

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.

Journal: Cancer cell
Published: May 20, 2022
Showing 1-10 of 10

Last Updated: 09/26/2026